Current Protein Identity：Q8WY64
New Search
Difference tags compare only the current result set; every original PDB and assembly record remains separate.
Related-Structure Differences
Each row represents one biological assembly in one PDB entry; multiple monomers of the same protein are listed separately.
| PDB Entry | Assembly / Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Non-polymers | Experimental Method | Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|---|
| 13RZ PanDDA analysis group deposition -- IDOL RING domain in complex with Z1118527729 Deposited 2025-10-10 | Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain A
369–445（77 aa）
Chain B
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 A1CX8 2-{[(1R,2R)-2-methylcyclopentyl]amino}ethan-1-ol × 3 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.66 Å R-free 0.229 |
| 13RZ PanDDA analysis group deposition -- IDOL RING domain in complex with Z1118527729 Deposited 2025-10-10 | Assembly 2 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain C
369–445（77 aa）
Chain D
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 A1CX8 2-{[(1R,2R)-2-methylcyclopentyl]amino}ethan-1-ol × 1 DMS DIMETHYL SULFOXIDE × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.66 Å R-free 0.229 |
| 13SA PanDDA analysis group deposition -- IDOL RING domain in complex with Z1251361039 Deposited 2025-10-10 | Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain A
369–445（77 aa）
Chain B
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 ACT ACETATE ION × 1 A1CYA (2R)-2-hydroxy-N-[(Z)-(pyridin-2-yl)methylidene]propanamide × 1 DMS DIMETHYL SULFOXIDE × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.57 Å R-free 0.234 |
| 13SA PanDDA analysis group deposition -- IDOL RING domain in complex with Z1251361039 Deposited 2025-10-10 | Assembly 2 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain C
369–445（77 aa）
Chain D
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 DMS DIMETHYL SULFOXIDE × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.57 Å R-free 0.234 |
| 13SB PanDDA analysis group deposition -- IDOL RING domain in complex with Z1456069604 Deposited 2025-10-10 | Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain A
369–445（77 aa）
Chain B
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 KF8 N-[(3S)-piperidin-3-yl]benzamide × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.48 Å R-free 0.218 |
| 13SB PanDDA analysis group deposition -- IDOL RING domain in complex with Z1456069604 Deposited 2025-10-10 | Assembly 2 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain C
369–445（77 aa）
Chain D
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 KF8 N-[(3S)-piperidin-3-yl]benzamide × 1 DMS DIMETHYL SULFOXIDE × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.48 Å R-free 0.218 |
| 13SC PanDDA analysis group deposition -- IDOL RING domain in complex with Z1491353358 Deposited 2025-10-10 | Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain A
369–445（77 aa）
Chain B
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 WNM (3S)-1-(phenylsulfonyl)pyrrolidin-3-amine × 3 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.48 Å R-free 0.209 |
| 13SC PanDDA analysis group deposition -- IDOL RING domain in complex with Z1491353358 Deposited 2025-10-10 | Assembly 2 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain C
369–445（77 aa）
Chain D
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 WNM (3S)-1-(phenylsulfonyl)pyrrolidin-3-amine × 2 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.48 Å R-free 0.209 |
| 13SD PanDDA analysis group deposition -- IDOL RING domain in complex with Z1516316257 Deposited 2025-10-10 | Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain A
369–445（77 aa）
Chain B
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 A1CYB 3-ethyl-5-methyl-4-[(3-methyl-1H-pyrazol-1-yl)methyl]-1,2-oxazole × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.52 Å R-free 0.192 |
| 13SD PanDDA analysis group deposition -- IDOL RING domain in complex with Z1516316257 Deposited 2025-10-10 | Assembly 2 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain C
369–445（77 aa）
Chain D
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.52 Å R-free 0.192 |
| 13SE PanDDA analysis group deposition -- IDOL RING domain in complex with Z1587220559 Deposited 2025-10-10 | Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain C
369–445（77 aa）
Chain D
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.44 Å R-free 0.198 |
| 13SE PanDDA analysis group deposition -- IDOL RING domain in complex with Z1587220559 Deposited 2025-10-10 | Assembly 2 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain A
369–445（77 aa）
Chain B
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 T1J 2-{[(1H-benzimidazol-2-yl)amino]methyl}phenol × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.44 Å R-free 0.198 |
| 13SF PanDDA analysis group deposition -- IDOL RING domain in complex with Z1685106505 Deposited 2025-10-10 | Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain A
369–445（77 aa）
Chain B
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 TQC (3M)-5-cyclobutyl-3-(1-methyl-1H-imidazol-2-yl)-1,2,4-oxadiazole × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.71 Å R-free 0.265 |
| 13SF PanDDA analysis group deposition -- IDOL RING domain in complex with Z1685106505 Deposited 2025-10-10 | Assembly 2 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain C
369–445（77 aa）
Chain D
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.71 Å R-free 0.265 |
| 13SG PanDDA analysis group deposition -- IDOL RING domain in complex with Z1891773476 Deposited 2025-10-10 | Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain A
369–445（77 aa）
Chain B
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 DMS DIMETHYL SULFOXIDE × 1 A1BNE 1-[(2R)-2,3-dihydro-1,4-benzodioxin-2-yl]-N-methylmethanamine × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.73 Å R-free 0.239 |
| 13SG PanDDA analysis group deposition -- IDOL RING domain in complex with Z1891773476 Deposited 2025-10-10 | Assembly 2 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain C
369–445（77 aa）
Chain D
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 DMS DIMETHYL SULFOXIDE × 1 A1BNE 1-[(2R)-2,3-dihydro-1,4-benzodioxin-2-yl]-N-methylmethanamine × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.73 Å R-free 0.239 |
| 13SH PanDDA analysis group deposition -- IDOL RING domain in complex with Z234898049 Deposited 2025-10-10 | Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain A
369–445（77 aa）
Chain B
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 A1CYF 3-(5-methyl-1,2,4-oxadiazol-3-yl)aniline × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.60 Å R-free 0.233 |
| 13SH PanDDA analysis group deposition -- IDOL RING domain in complex with Z234898049 Deposited 2025-10-10 | Assembly 2 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain C
369–445（77 aa）
Chain D
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 A1CYF 3-(5-methyl-1,2,4-oxadiazol-3-yl)aniline × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.60 Å R-free 0.233 |
| 13SI PanDDA analysis group deposition -- IDOL RING domain in complex with Z2574937229 Deposited 2025-10-10 | Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain A
369–445（77 aa）
Chain B
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 WJG (S)-1-(4-methoxyphenyl)-1-phenylmethanamine × 2 DMS DIMETHYL SULFOXIDE × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.54 Å R-free 0.211 |
| 13SI PanDDA analysis group deposition -- IDOL RING domain in complex with Z2574937229 Deposited 2025-10-10 | Assembly 2 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain C
369–445（77 aa）
Chain D
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 WJG (S)-1-(4-methoxyphenyl)-1-phenylmethanamine × 2 DMS DIMETHYL SULFOXIDE × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.54 Å R-free 0.211 |
| 13SJ PanDDA analysis group deposition -- IDOL RING domain in complex with Z2643472210 Deposited 2025-10-10 | Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain A
369–445（77 aa）
Chain B
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 JGY 1-methyl-N-{[(2S)-oxolan-2-yl]methyl}-1H-pyrazole-3-carboxamide × 3 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.47 Å R-free 0.204 |
| 13SJ PanDDA analysis group deposition -- IDOL RING domain in complex with Z2643472210 Deposited 2025-10-10 | Assembly 2 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain C
369–445（77 aa）
Chain D
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.47 Å R-free 0.204 |
| 13SK PanDDA analysis group deposition -- IDOL RING domain in complex with Z2692078340 Deposited 2025-10-10 | Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain A
369–445（77 aa）
Chain B
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 W1Y N-methyl-1-(1-phenyl-1H-pyrazol-4-yl)methanamine × 2 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.54 Å R-free 0.230 |
| 13SK PanDDA analysis group deposition -- IDOL RING domain in complex with Z2692078340 Deposited 2025-10-10 | Assembly 2 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain C
369–445（77 aa）
Chain D
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 W1Y N-methyl-1-(1-phenyl-1H-pyrazol-4-yl)methanamine × 2 DMS DIMETHYL SULFOXIDE × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.54 Å R-free 0.230 |
| 13SL PanDDA analysis group deposition -- IDOL RING domain in complex with Z275151340 Deposited 2025-10-10 | Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain A
369–445（77 aa）
Chain B
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 JHP 4-chloro-N-cyclopentyl-1-methyl-1H-pyrazole-3-carboxamide × 2 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.34 Å R-free 0.214 |
| 13SL PanDDA analysis group deposition -- IDOL RING domain in complex with Z275151340 Deposited 2025-10-10 | Assembly 2 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain C
369–445（77 aa）
Chain D
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 JHP 4-chloro-N-cyclopentyl-1-methyl-1H-pyrazole-3-carboxamide × 2 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.34 Å R-free 0.214 |
| 13SM PanDDA analysis group deposition -- IDOL RING domain in complex with Z275179946 Deposited 2025-10-10 | Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain A
369–445（77 aa）
Chain B
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 GW1 (4-chloranyl-2-methyl-pyrazol-3-yl)-piperidin-1-yl-methanone × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.40 Å R-free 0.205 |
| 13SM PanDDA analysis group deposition -- IDOL RING domain in complex with Z275179946 Deposited 2025-10-10 | Assembly 2 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain C
369–445（77 aa）
Chain D
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 GW1 (4-chloranyl-2-methyl-pyrazol-3-yl)-piperidin-1-yl-methanone × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.40 Å R-free 0.205 |
| 13SN PanDDA analysis group deposition -- IDOL RING domain in complex with Z2757439080 Deposited 2025-10-10 | Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain A
369–445（77 aa）
Chain B
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 Q7L (3P)-3-(2H-1,3-benzodioxol-5-yl)-1H-pyrazole × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.44 Å R-free 0.204 |
| 13SN PanDDA analysis group deposition -- IDOL RING domain in complex with Z2757439080 Deposited 2025-10-10 | Assembly 2 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain C
369–445（77 aa）
Chain D
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 Q7L (3P)-3-(2H-1,3-benzodioxol-5-yl)-1H-pyrazole × 2 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.44 Å R-free 0.204 |
| 13SO PanDDA analysis group deposition -- IDOL RING domain in complex with Z285233820 Deposited 2025-10-10 | Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain A
369–445（77 aa）
Chain B
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 KB3 (5M)-5-(2-methoxyphenyl)-1,3,4-oxadiazol-2-amine × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.61 Å R-free 0.226 |
| 13SO PanDDA analysis group deposition -- IDOL RING domain in complex with Z285233820 Deposited 2025-10-10 | Assembly 2 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain C
369–445（77 aa）
Chain D
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 KB3 (5M)-5-(2-methoxyphenyl)-1,3,4-oxadiazol-2-amine × 1 DMS DIMETHYL SULFOXIDE × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.61 Å R-free 0.226 |
| 13SP PanDDA analysis group deposition -- IDOL RING domain in complex with Z364577298 Deposited 2025-10-10 | Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain A
369–445（77 aa）
Chain B
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 A1CYC 1-[(3S)-3-methylmorpholin-4-yl]-2-[3-(trifluoromethyl)-1H-pyrazol-1-yl]ethan-1-one × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.69 Å R-free 0.261 |
| 13SP PanDDA analysis group deposition -- IDOL RING domain in complex with Z364577298 Deposited 2025-10-10 | Assembly 2 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain C
369–445（77 aa）
Chain D
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.69 Å R-free 0.261 |
| 13SQ PanDDA analysis group deposition -- IDOL RING domain in complex with Z369936976 Deposited 2025-10-10 | Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain A
369–445（77 aa）
Chain B
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 U0P N'-cyclopropyl-N-methyl-N-[(5-methyl-1,2-oxazol-3-yl)methyl]urea × 1 DMS DIMETHYL SULFOXIDE × 2 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.30 Å R-free 0.200 |
| 13SQ PanDDA analysis group deposition -- IDOL RING domain in complex with Z369936976 Deposited 2025-10-10 | Assembly 2 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain C
369–445（77 aa）
Chain D
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 U0P N'-cyclopropyl-N-methyl-N-[(5-methyl-1,2-oxazol-3-yl)methyl]urea × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.30 Å R-free 0.200 |
| 13SR PanDDA analysis group deposition -- IDOL RING domain in complex with Z48852953 Deposited 2025-10-10 | Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain A
369–445（77 aa）
Chain B
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 A1CYD 4-methyl-N-{[(2S)-oxolan-2-yl]methyl}-1,3-thiazol-2-amine × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.65 Å R-free 0.230 |
| 13SR PanDDA analysis group deposition -- IDOL RING domain in complex with Z48852953 Deposited 2025-10-10 | Assembly 2 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain C
369–445（77 aa）
Chain D
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 A1CYD 4-methyl-N-{[(2S)-oxolan-2-yl]methyl}-1,3-thiazol-2-amine × 1 DMS DIMETHYL SULFOXIDE × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.65 Å R-free 0.230 |
| 13SS PanDDA analysis group deposition -- IDOL RING domain in complex with Z57475877 Deposited 2025-10-10 | Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain A
369–445（77 aa）
Chain B
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 S7S ~{N}-(2-ethyl-1,2,3,4-tetrazol-5-yl)butanamide × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.69 Å R-free 0.234 |
| 13SS PanDDA analysis group deposition -- IDOL RING domain in complex with Z57475877 Deposited 2025-10-10 | Assembly 2 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain C
369–445（77 aa）
Chain D
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 DMS DIMETHYL SULFOXIDE × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.69 Å R-free 0.234 |
| 13ST PanDDA analysis group deposition -- IDOL RING domain in complex with Z608065044 Deposited 2025-10-10 | Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain A
369–445（77 aa）
Chain B
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 DMS DIMETHYL SULFOXIDE × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.37 Å R-free 0.200 |
| 13ST PanDDA analysis group deposition -- IDOL RING domain in complex with Z608065044 Deposited 2025-10-10 | Assembly 2 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain C
369–445（77 aa）
Chain D
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 A1H9V ~{N},~{N}-dimethyl-1~{H}-pyrazole-4-sulfonamide × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.37 Å R-free 0.200 |
| 13SU PanDDA analysis group deposition -- IDOL RING domain in complex with Z68404778 Deposited 2025-10-10 | Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain A
369–445（77 aa）
Chain B
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 B1A ~{N}-(4-phenylazanylphenyl)ethanamide × 1 DMS DIMETHYL SULFOXIDE × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.50 Å R-free 0.201 |
| 13SU PanDDA analysis group deposition -- IDOL RING domain in complex with Z68404778 Deposited 2025-10-10 | Assembly 2 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain C
369–445（77 aa）
Chain D
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.50 Å R-free 0.201 |
| 13SV PanDDA analysis group deposition -- IDOL RING domain in complex with Z954606858 Deposited 2025-10-10 | Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain A
369–445（77 aa）
Chain B
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 VW4 (2S)-2-phenylpropane-1-sulfonamide × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.68 Å R-free 0.233 |
| 13SV PanDDA analysis group deposition -- IDOL RING domain in complex with Z954606858 Deposited 2025-10-10 | Assembly 2 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain C
369–445（77 aa）
Chain D
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 DMS DIMETHYL SULFOXIDE × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.68 Å R-free 0.233 |
| 13SW PanDDA analysis group deposition -- IDOL RING domain in complex with POB0087 Deposited 2025-10-10 | Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain A
369–445（77 aa）
Chain B
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 A1AJM (3S)-3-(4-fluorophenyl)piperidine-3-carboxamide × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.37 Å R-free 0.213 |
| 13SW PanDDA analysis group deposition -- IDOL RING domain in complex with POB0087 Deposited 2025-10-10 | Assembly 2 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain C
369–445（77 aa）
Chain D
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.37 Å R-free 0.213 |
| 13SX PanDDA analysis group deposition -- IDOL RING domain in complex with POB0134 Deposited 2025-10-10 | Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain A
369–445（77 aa）
Chain B
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.36 Å R-free 0.199 |
| 13SX PanDDA analysis group deposition -- IDOL RING domain in complex with POB0134 Deposited 2025-10-10 | Assembly 2 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain C
369–445（77 aa）
Chain D
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 A1CYE methyl (3R,4R)-4-(3-methoxyphenyl)oxane-3-carboxylate × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.36 Å R-free 0.199 |
| 13SY PanDDA analysis group deposition -- IDOL RING domain in complex with POB0041 Deposited 2025-10-10 | Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain A
369–445（77 aa）
Chain B
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 W2J [(3R,5R)-5-methylpiperidin-3-yl]methanol × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.29 Å R-free 0.203 |
| 13SY PanDDA analysis group deposition -- IDOL RING domain in complex with POB0041 Deposited 2025-10-10 | Assembly 2 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain C
369–445（77 aa）
Chain D
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 W2J [(3R,5R)-5-methylpiperidin-3-yl]methanol × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.29 Å R-free 0.203 |
| 13SZ PanDDA analysis group deposition -- IDOL RING domain in complex with NCL-00023835 Deposited 2025-10-10 | Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain A
369–445（77 aa）
Chain B
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 A1H6Y 1-bromanyl-4-methylsulfonyl-benzene × 2 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.49 Å R-free 0.214 |
| 13SZ PanDDA analysis group deposition -- IDOL RING domain in complex with NCL-00023835 Deposited 2025-10-10 | Assembly 2 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain C
369–445（77 aa）
Chain D
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 A1H6Y 1-bromanyl-4-methylsulfonyl-benzene × 2 DMS DIMETHYL SULFOXIDE × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.49 Å R-free 0.214 |
| 13TA PanDDA analysis group deposition -- IDOL RING domain in complex with Z1741976468 Deposited 2025-10-10 | Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain A
369–445（77 aa）
Chain B
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 XJV imidazolidin-2-one × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.51 Å R-free 0.222 |
| 13TA PanDDA analysis group deposition -- IDOL RING domain in complex with Z1741976468 Deposited 2025-10-10 | Assembly 2 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain C
369–445（77 aa）
Chain D
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 XJV imidazolidin-2-one × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.51 Å R-free 0.222 |
| 13TB PanDDA analysis group deposition -- IDOL RING domain in complex with Z2301685688 Deposited 2025-10-10 | Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain A
369–445（77 aa）
Chain B
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 W3M 1H-imidazole-5-carbonitrile × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.55 Å R-free 0.218 |
| 13TB PanDDA analysis group deposition -- IDOL RING domain in complex with Z2301685688 Deposited 2025-10-10 | Assembly 2 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain C
369–445（77 aa）
Chain D
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 W3M 1H-imidazole-5-carbonitrile × 2 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.55 Å R-free 0.218 |
| 2YHN The IDOL-UBE2D complex mediates sterol-dependent degradation of the LDL receptor Deposited 2011-05-04 | Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain A
369–445（77 aa）
Fragment：RING, RESIDUES 369-445
Chain B
369–445（77 aa）
Fragment：RING, RESIDUES 369-445
|
Not recorded | ZN ZINC ION × 4 | X-RAY DIFFRACTION |
X-ray crystallization conditions
pH 7.5；0.1 M SODIUM ACETATE PH 7-8, 16-20% MPD.
|
Resolution 3.00 Å R-free 0.297 |
| 2YHO The IDOL-UBE2D complex mediates sterol-dependent degradation of the LDL receptor Deposited 2011-05-04 | Assembly 1 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain A
369–445（77 aa）
Fragment：RING, RESIDUES 369-445
|
Not recorded | ZN ZINC ION × 2 ACT ACETATE ION × 4 | X-RAY DIFFRACTION |
X-ray crystallization conditions
pH 5.5；0.1 M SODIUM CITRATE PH 5.5, 0.2 M SODIUM ACETATE, 10% PEG 4000
|
Resolution 2.10 Å R-free 0.233 |
| 2YHO The IDOL-UBE2D complex mediates sterol-dependent degradation of the LDL receptor Deposited 2011-05-04 | Assembly 2 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain C
369–445（77 aa）
Fragment：RING, RESIDUES 369-445
|
Not recorded | ZN ZINC ION × 2 | X-RAY DIFFRACTION |
X-ray crystallization conditions
pH 5.5；0.1 M SODIUM CITRATE PH 5.5, 0.2 M SODIUM ACETATE, 10% PEG 4000
|
Resolution 2.10 Å R-free 0.233 |
| 2YHO The IDOL-UBE2D complex mediates sterol-dependent degradation of the LDL receptor Deposited 2011-05-04 | Assembly 3 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain E
369–445（77 aa）
Fragment：RING, RESIDUES 369-445
|
Not recorded | ZN ZINC ION × 2 ACT ACETATE ION × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
pH 5.5；0.1 M SODIUM CITRATE PH 5.5, 0.2 M SODIUM ACETATE, 10% PEG 4000
|
Resolution 2.10 Å R-free 0.233 |
| 2YHO The IDOL-UBE2D complex mediates sterol-dependent degradation of the LDL receptor Deposited 2011-05-04 | Assembly 4 Protein heterocomplex Heteromer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain G
369–445（77 aa）
Fragment：RING, RESIDUES 369-445
|
Not recorded | ZN ZINC ION × 2 ACT ACETATE ION × 4 | X-RAY DIFFRACTION |
X-ray crystallization conditions
pH 5.5；0.1 M SODIUM CITRATE PH 5.5, 0.2 M SODIUM ACETATE, 10% PEG 4000
|
Resolution 2.10 Å R-free 0.233 |
| 6QLY IDOL FERM domain Deposited 2019-02-01 | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count |
Chain A
1–344（344 aa）
|
Not recorded | SO4 SULFATE ION × 1 EDO 1,2-ETHANEDIOL × 2 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；293 K；100mM Tris pH 8.5,
20mM MgSO4,
4% (w/v) ethylene glycol,
12% (w/v) 2-Methyl-2,4-pentanediol (MPD)
|
Resolution 2.50 Å R-free 0.247 |
| 6QLY IDOL FERM domain Deposited 2019-02-01 | Assembly 2 Protein homooligomer Homooligomer；Protein × 4 PDB declaration: tetrameric（4） Consistent with protein count |
Chain A
1–344（344 aa）
|
Not recorded | SO4 SULFATE ION × 4 EDO 1,2-ETHANEDIOL × 8 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；293 K；100mM Tris pH 8.5,
20mM MgSO4,
4% (w/v) ethylene glycol,
12% (w/v) 2-Methyl-2,4-pentanediol (MPD)
|
Resolution 2.50 Å R-free 0.247 |
| 6QLZ IDOL F3ab subdomain Deposited 2019-02-01 | Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count |
Chain A
183–283（101 aa）
|
Not recorded | No recorded non-water small molecule | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 7；293 K；100mM Hepes pH 7.0
10% (w/v) PEG 6000
|
Resolution 2.34 Å |
| 6QLZ IDOL F3ab subdomain Deposited 2019-02-01 | Assembly 2 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count |
Chain B
183–283（101 aa）
|
Not recorded | No recorded non-water small molecule | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 7；293 K；100mM Hepes pH 7.0
10% (w/v) PEG 6000
|
Resolution 2.34 Å |
| 6QLZ IDOL F3ab subdomain Deposited 2019-02-01 | Assembly 3 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count |
Chain C
183–283（101 aa）
|
Not recorded | No recorded non-water small molecule | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 7；293 K；100mM Hepes pH 7.0
10% (w/v) PEG 6000
|
Resolution 2.34 Å |
| 9SA1 The RING domain of IDOL Deposited 2025-08-07 | Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain A
369–445（77 aa）
Chain B
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 5.5；293 K；200 mM Magnesium chloride hexahydrate, 100 mM Bis-tris, 25% w/v PEG 3350
|
Resolution 1.06 Å R-free 0.177 |
| 9SA2 The RING domain of IDOL Deposited 2025-08-07 | Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain A
369–445（77 aa）
Chain B
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 EDO 1,2-ETHANEDIOL × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.10 Å R-free 0.174 |
| 9SA2 The RING domain of IDOL Deposited 2025-08-07 | Assembly 2 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric（2） Consistent with protein count |
Chain C
369–445（77 aa）
Chain D
369–445（77 aa）
|
Not recorded | ZN ZINC ION × 4 EDO 1,2-ETHANEDIOL × 1 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；293 K；200 mM Sodium acetate, 100 mM Tris, 30% w/v PEG 4000
|
Resolution 1.10 Å R-free 0.174 |